Functional importance of T-type voltage-gated calcium channels in the cardiovascular and renal system: News from the world of knockout mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 308, Issue 4, 2015, Pages R227-R237

  Hansen, Pernille B L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Blood vessels; Calcium antagonist; Calcium blocker; Cardiovascular disease

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; NITRIC OXIDE; T TYPE VOLTAGE GATED CALCIUM CHANNEL CAV3.1; T TYPE VOLTAGE GATED CALCIUM CHANNEL CAV3.2; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL FUNCTION; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; DRUG TARGETING; EVALUATION STUDY; GLOMERULUS FILTRATION RATE; HEART HEMODYNAMICS; HEART RATE; HEART VENTRICLE HYPERTROPHY; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KNOCKOUT MOUSE; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; VASCULAR DISEASE; VASOCONSTRICTION; VASODILATATION; ADRENERGIC SYSTEM; ANIMAL; CALCIUM SIGNALING; CARDIOVASCULAR DISEASES; DRUG EFFECTS; GENETICS; GENOTYPE; HEMODYNAMICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CALCIUM SIGNALING; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; GENOTYPE; HEMODYNAMICS; HUMANS; KIDNEY; MICE, KNOCKOUT; PHENOTYPE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84923165548     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00276.2014     Document Type: Review

References (116)

1. 2+ channels in rat cerebral arteries: role in myogenic tone development. Am J Physiol Heart Circ Physiol 304: H58–H71, 2013.
2. Abe M, Okada K, Maruyama N, Matsumoto S, Maruyama T, Fujita T, Matsumoto K, Soma M. Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria. Hypertens Res 34: 268–273, 2011.
3. Arima S, Ito S, Omata K, Tsunoda K, Yaoita H, Abe K. Diverse effects of calcium antagonists on glomerular hemodynamics. Kidney Int Suppl 55: S132–S134, 1996.
4. Ball CJ, Wilson DP, Turner SP, Saint DA, Beltrame JF. Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade. Hypertension 53: 654–660, 2009.
5. 2+ channel. Acta Physiol (Oxf) 207: 709–720, 2013.
6. Bohn G, Moosmang S, Conrad H, Ludwig A, Hofmann F, Klugbauer N. Expression of T- and L-type calcium channel mRNA in murine sinoatrial node. FEBS Lett 481: 73–76, 2000.
7. Bossu JL, Elhamdani A, Feltz A. Voltage-dependent calcium entry in confluent bovine capillary endothelial cells. FEBS Lett 299: 239–242, 1992.
8. Braunstein TH, Inoue R, Cribbs L, Oike M, Ito Y, Holstein-Rathlou NH, Jensen LJ. The role of L- and T-type calcium channels in local and remote calcium responses in rat mesenteric terminal arterioles. J Vasc Res 46: 138–151, 2008.
9. 2+] in renal arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 265: F677–F685, 1993.
10. Cazade M, Bidaud I, Hansen PB, Lory P, Chemin J. A 5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone. Pflügers Arch 466: 1759–1768, 2014.
11. 2+ channel-gating properties. Biophys J 80: 1238–1250, 2001.
12. Chen CC, Fan YP, Shin HS, Su CK. Basal sympathetic activity generated in neonatal mouse brainstem-spinal cord preparation requires T-type calcium channel subunit 1H. Exp Physiol 96: 486–494, 2011.
13. 2+ channels. Science 302: 1416–1418, 2003.
14. Chen CC, Shen JW, Chung NC, Min MY, Cheng SJ, Liu IY. Retrieval of context-associated memory is dependent on the Ca(v)3.2 T-type calcium channel. PloS One 7: e29384, 2012.
15. +. Am J Physiol Renal Physiol 276: F674–F683, 1999.
16. 2+ channels in normal and abnormal brain functions. Physiol Rev 93: 961–992, 2013.
17. 2+ channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res 104: 522–530, 2009.
18. 2+ channels in vascular smooth muscle: multiple functions. Cell Calcium 40: 221–230, 2006.
19. Dilley JR, Stier CT Jr, Arendshorst WJ. Abnormalities in glomerular function in rats developing spontaneous hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 246: F12–F20, 1984.
20. Emerick MC, Stein R, Kunze R, Mc Nulty MM, Regan MR, Hanck DA, Agnew WS. Profiling the array of Ca(v)3.1 variants from the human T-type calcium channel gene CACNA1G: alternative structures, developmental expression, and biophysical variations. Proteins 64: 320–342, 2006.
21. Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez- Reyes E, Schwartz A, Snutch TP, Tanabe T, Birnbaumer L, Tsien RW, Catterall WA. Nomenclature of voltage-gated calcium channels. Neuron 25: 533–535, 2000.
22. Feng MG, Li M, Navar LG. T-type calcium channels in the regulation of afferent and efferent arterioles in rats. Am J Physiol Renal Physiol 286: F331–F337, 2004.
23. Figueroa XF, Chen CC, Campbell KP, Damon DN, Day KH, Ramos S, Duling BR. Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? Am J Physiol Heart Circ Physiol 293: H1371–H1383, 2007.
24. 2+ channel (alpha1G) expressed in Xenopus oocytes. J Cardiovasc Pharmacol 45: 241–246, 2005.
25. 2+ channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)32 (alpha(1H)), and Ca(v)33 (alpha(1I))) expressed in Xenopus oocytes. Eur J Pharmacol 613: 100–107, 2009.
26. Giordanetto F, Knerr L, Selmi N, Llinas A, Lindqvist A, Wang QD, Stahlberg P, Thorstensson F, Ullah V, Nilsson K, O’Mahony G, Hogberg G, Lindhardt E, Strand A, Duker G. Discovery of N-(1- adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors. Bioorg Med Chem Lett 21: 5557–5561, 2011.
27. Giordanetto F, Knerr L, Wallberg A. T-type calcium channels inhibitors: a patent review. Expert Opin Ther Pat 21: 85–101, 2011.
28. Gordienko DV, Clausen C, Goligorsky MS. Ionic currents and endothelin signaling in smooth muscle cells from rat renal resistance arteries. Am J Physiol Renal Fluid Electrolyte Physiol 266: F325–F341, 1994.
29. 2+ channels. Am J Physiol Heart Circ Physiol 280: H582–H590, 2001.
30. Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 395: 233–253, 1988.
31. Hansen PB. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels. Acta Physiol (Oxf) 207: 690–699, 2013.
32. Hansen PB, Jensen BL, Andreasen D, Skott O. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res 89: 630–638, 2001.
33. Hansen PB, Poulsen CB, Walter S, Marcussen N, Cribbs LL, Skott O, Jensen BL. Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. Hypertension 58: 464– 470, 2011.
34. Harada K, Nomura M, Nishikado A, Uehara K, Nakaya Y, Ito S. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities. Circ J 67: 139–145, 2003.
35. Harraz OF, Abd El-Rahman RR, Bigdely-Shamloo K, Wilson SM, Brett SE, Romero M, Gonzales AL, Earley S, Vigmond E, Nygren A, Menon BK, Mufti RE, Watson TW, Starreveld YP, Furstenhaupt T, Muellerleile PR, Kurjiaka D, Kyle BD, Braun AP, Welsh DG. CaV3.2 channels and the induction of negative feedback in cerebral arteries. Circ Res 115: 650–661, 2014.
36. 2+ channels through cGMP/PKG signaling. Am J Physiol Heart Circ Physiol 306: H279–H285, 2014.
37. Hart P, Bakris GL. Calcium antagonists: Do they equally protect against kidney injury? Kidney Int 73: 795–796, 2008.
38. Hayashi K, Kumagai H, Saruta T. Effect of efonidipine and ACE inhibitors on proteinuria in human hypertension with renal impairment. Am J Hypertens 16: 116–122, 2003.
39. 2+ channel subtypes and pharmacology in the kidney. Circ Res 100: 342–353, 2007.
40. 2+]i responses to ANG II. Am J Physiol Renal Physiol 273: F84–F96, 1997.
41. Hobom M, Dai S, Marais E, Lacinova L, Hofmann F, Klugbauer N. Neuronal distribution and functional characterization of the calcium channel α2δ-2 subunit. Eur J Neurosci 12: 1217–1226, 2000.
42. Hofmann F, Lacinova L, Klugbauer N. Voltage-dependent calcium channels: from structure to function. Rev Physiol Biochem Pharmacol 139: 33–87, 1999.
43. Homma K, Hayashi K, Yamaguchi S, Fujishima S, Hori S, Itoh H. Renal microcirculation and calcium channel subtypes. Curr Hypertens Rev 9: 182–186, 2013.
44. Howitt L, Chaston DJ, Sandow SL, Matthaei KI, Edwards FR, Hill CE. Spreading vasodilatation in the murine microcirculation: attenuation by oxidative stress-induced change in electromechanical coupling. J Physiol 591: 2157–2173, 2013.
45. Howitt L, Kuo IY, Ellis A, Chaston DJ, Shin HS, Hansen PB, Hill CE. Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium channel contribution to vascular tone of rodent arteries and arterioles. Cardiovasc Res 98: 449–457, 2013.
46. Hsu SC, Chang YT, Chen CC. Early growth response 1 is an early signal inducing Cav3.2 T-type calcium channels during cardiac hypertrophy. Cardiovasc Res 100: 222–230, 2013.
47. 2+ release contributes to automaticity in cat atrial pacemaker cells. J Physiol 524: 415–422, 2000.
48. Iftinca M, Hamid J, Chen L, Varela D, Tadayonnejad R, Altier C, Turner RW, Zamponi GW. Regulation of T-type calcium channels by Rho-associated kinase. Nat Neurosci 10: 854–860, 2007.
49. 2+ channels in regulation of vasomotor tone in mesenteric arterioles? Can J Physiol Pharmacol 87: 8–20, 2009.
50. Jensen LJ, Salomonsson M, Jensen BL, Holstein-Rathlou NH. Depolarization- induced calcium influx in rat mesenteric small arterioles is mediated exclusively via mibefradil-sensitive calcium channels. Br J Pharmacol 142: 709–718, 2004.
51. 2+ channels. Neuron 31: 35–45, 2001.
52. Koh KK, Quon MJ, Lee SJ, Han SH, Ahn JY, Kim JA, Chung WJ, Lee Y, Shin EK. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension. Diabetes Care 30: 1605–1607, 2007.
53. 2+ signaling. Am J Physiol Heart Circ Physiol 289: H1326–H1334, 2005.
54. Krattinger N, Capponi A, Mazzolai L, Aubert JF, Caille D, Nicod P, Waeber G, Meda P, Haefliger JA. Connexin40 regulates renin production and blood pressure. Kidney Int 72: 814–822, 2007.
55. 2+ currents in rat aortic smooth muscle cells in primary culture. Circ Res 79: 14–19, 1996.
56. Kuo IY, Ellis A, Seymour VA, Sandow SL, Hill CE. Dihydropyridineinsensitive calcium currents contribute to function of small cerebral arteries. J Cereb Blood Flow Metab 30: 1226–1239, 2010.
57. Kuo IY, Howitt L, Sandow SL, McFarlane A, Hansen PB, Hill CE. Role of T-type channels in vasomotor function: team player or chameleon? Pflügers Arch 466: 767–779, 2014.
58. Kuo IY, Wolfle SE, Hill CE. T-type calcium channels and vascular function: the new kid on the block? J Physiol 589: 783–795, 2011.
59. Lee J, Kim D, Shin HS. Lack of delta waves and sleep disturbances during non-rapid eye movement sleep in mice lacking alpha1G-subunit of T-type calcium channels. Proc Natl Acad Sci USA 101: 18195–18199, 2004.
60. Li X, Yang MS. Effects of T-type calcium channel blockers on renal function and aldosterone in patients with hypertension: a systematic review and meta-analysis. PloS One 9: e109834, 2014.
61. Li Y, Wang F, Zhang X, Qi Z, Tang M, Szeto C, Li Y, Zhang H, Chen X. β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A. PloS One 7: e39965, 2012.
62. 2+ entry. Circ Res 87: 551–557, 2000.
63. Loutzenhiser R, Chilton L, Trottier G. Membrane potential measurements in renal afferent and efferent arterioles: actions of angiotensin II. Am J Physiol Renal Physiol 273: F307–F314, 1997.
64. Mangoni ME, Nargeot J. Genesis and regulation of the heart automaticity. Physiol Rev 88: 919–982, 2008.
65. Mangoni ME, Nargeot J. Properties of the hyperpolarization-activated current (I(f)) in isolated mouse sino-atrial cells. Cardiovasc Res 52: 51–64, 2001.
66. Mangoni ME, Traboulsie A, Leoni AL, Couette B, Marger L, Le Quang K, Kupfer E, Cohen-Solal A, Vilar J, Shin HS, Escande D, Charpentier F, Nargeot J, Lory P. Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/α1G T-type calcium channels. Circ Res 98: 1422–1430, 2006.
67. Marger L, Mesirca P, Alig J, Torrente A, Dubel S, Engeland B, Kanani S, Fontanaud P, Striessnig J, Shin HS, Isbrandt D, Ehmke H, Nargeot J, Mangoni ME. Functional roles of Ca(v)1.3, Ca(v)3.1 and HCN channels in automaticity of mouse atrioventricular cells: insights into the atrioventricular pacemaker mechanism. Channels 5: 251–261, 2011.
68. 2+ channels in ventricular cells from hypertrophied rat hearts. J Mol Cell Cardiol 31: 1617–1625, 1999.
69. 2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice. J Clin Invest 119: 3787–3796, 2009.
70. Navar LG, Inscho EW, Imig JD, Mitchell KD. Heterogeneous activation mechanisms in the renal microvasculature. Kidney Int Suppl 67: S17–S21, 1998.
71. Navarro-Gonzalez MF, Grayson TH, Meaney KR, Cribbs LL, Hill CE. Non-L-type voltage-dependent calcium channels control vascular tone of the rat basilar artery. Clin Exp Pharmacol Physiol 36: 55–66, 2009.
72. Nikitina E, Zhang ZD, Kawashima A, Jahromi BS, Bouryi VA, Takahashi M, Xie A, Macdonald RL. Voltage-dependent calcium channels of dog basilar artery. J Physiol 580: 523–541, 2007.
73. Nilius B, Talavera K, Verkhratsky A. T-type calcium channels: the never ending story. Cell Calcium 40: 81–88, 2006.
74. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 73: 777–782, 1993.
75. Ohishi M, Takagi T, Ito N, Terai M, Tatara Y, Hayashi N, Shiota A, Katsuya T, Rakugi H, Ogihara T. Renal-protective effect of T- and L-type calcium channel blockers in hypertensive patients: an amlodipineto- benidipine changeover (ABC) study. Hypertens Res 30: 797–806, 2007.
76. Ohta M, Sugawara S, Sato N, Kuriyama C, Hoshino C, Kikuchi A. Effects of benidipine, a long-acting T-type calcium channel blocker, on home blood pressure and renal function in patients with essential hypertension: a retrospective, ‘real-world’ comparison with amlodipine. Clin Drug Investig 29: 739–746, 2009.
77. 2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers. Hypertens Res 29: 493–497, 2006.
78. Oshima T, Ozono R, Yano Y, Higashi Y, Teragawa H, Miho N, Ishida T, Ishida M, Yoshizumi M, Kambe M. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension. Hypertens Res 28: 889–894, 2005.
79. Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Saruta T. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney. Hypertension 38: 343–347, 2001.
80. Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83: 117–161, 2003.
81. 2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. J Pharmacol Exp Ther 328: 621–627, 2009.
82. Poulsen CB, Al-Mashhadi RH, Cribbs LL, Skott O, Hansen PB. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles. Kidney Int 79: 443–451.
83. 2+ channel and dystrophin expression after balloon injury in rat aortic cells. Cardiovasc Res 49: 177–188, 2001.
84. Rehak R, Bartoletti TM, Engbers JD, Berecki G, Turner RW, Zamponi GW. Low voltage activation of KCa1.1 current by Cav3- KCa11 complexes. PLos One 8: e61844, 2013.
85. Rodman DM, Reese K, Harral J, Fouty B, Wu S, West J, Hoedt- Miller M, Tada Y, Li KX, Cool C, Fagan K, Cribbs L. Low-voltageactivated (T-type) calcium channels control proliferation of human pulmonary artery myocytes. Circ Res 96: 864–872, 2005.
86. Rossier MF, Ertel EA, Vallotton MB, Capponi AM. Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells. J Pharmacol Exp Ther 287: 824–831, 1998.
87. Sandmann S, Bohle RM, Dreyer T, Unger T. The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats. Virchows Arch 436: 147–157, 2000.
88. Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. J Atheroscler Thromb 16: 568–575, 2009.
89. Schjerning J, Uhrenholt TR, Svenningsen P, Vanhoutte PM, Skott O, Jensen BL, Hansen PB. Histamine-dependent prolongation by aldosterone of vasoconstriction in isolated small mesenteric arteries of the mouse. Am J Physiol Heart Circ Physiol 304: H1094–H1102, 2013.
90. Schmitt R, Clozel JP, Iberg N, Buhler FR. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. Arteriosclerosis, thrombosis, and vascular biology. 15: 1161–1165, 1995.
91. Schubert R, Mulvany MJ. The myogenic response: established facts and attractive hypotheses. Clin Sci 96: 313–326, 1999.
92. Sekiguchi F, Kawabata A. T-type calcium channels: functional regulation and implication in pain signaling. J Pharmacol Sci 122: 244–250, 2013.
93. 2+ channel antagonist. J Med Chem 51: 3692–3695, 2008.
94. Simms BA, Zamponi GW. Trafficking and stability of voltage-gated calcium channels. Cell Mol Life Sci 69: 843–856, 2012.
95. Skov K, Mulvany MJ, Korsgaard N. Morphology of renal afferent arterioles in spontaneously hypertensive rats. Hypertension 20: 821–827, 1992.
96. 2+ current. Cardiovasc Res 97: 293–301, 2013.
97. 2+ currents in single myocytes from human mesenteric arteries: evidence for a physiological role of L-type channels. J Physiol 457: 455–475, 1992.
98. Sugano N, Wakino S, Kanda T, Tatematsu S, Homma K, Yoshioka K, Hasegawa K, Hara Y, Suetsugu Y, Yoshizawa T, Hara Y, Utsunomiya Y, Tokudome G, Hosoya T, Saruta T, Hayashi K. T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Kidney Int 73: 826–834, 2008.
99. Svenningsen P, Andersen K, Thuesen AD, Shin HS, Vanhoutte PM, Skott O, Jensen BL, Hill C, Hansen PB. T-type Ca channels facilitate NO-formation, vasodilatation and NO-mediated modulation of blood pressure. Pflügers Arch 466: 2205–2214, 2014.
100. Tanaka T, Tsutamoto T, Sakai H, Fujii M, Yamamoto T, Horie M. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension. Hypertens Res 30: 691–697, 2007.
101. 2+ channels suppresses human breast cancer cell proliferation. Cancer Lett 267: 116–124, 2008.
102. Thuesen A, Andersen H, Cardel M, Toft A, Walter S, Marcussen Jensen B, Bie P, Hansen P. Differential effect of T-type voltage-gated calcium channel disruption on renal plasma flow and glomerular filtration rate in vivo. Am J Physiol Renal Physiol 307: F445–F452, 2014.
103. Turner RW, Anderson D, Zamponi GW. Signaling complexes of voltage-gated calcium channels. Channels 5: 440–448, 2011.
104. Tzeng BH, Chen YH, Huang CH, Lin SS, Lee KR, Chen CC. The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice. Cardiovasc Res 96: 533–542, 2012.
105. Uebele VN, Gotter AL, Nuss CE, Kraus RL, Doran SM, Garson SL, Reiss DR, Li Y, Barrow JC, Reger TS, Yang ZQ, Ballard JE, Tang C, Metzger JM, Wang SP, Koblan KS, Renger JJ. Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in mice. J Clin Invest 119: 1659–1667, 2009.
106. VanBavel E, Sorop O, Andreasen D, Pfaffendorf M, Jensen BL. Role of T-type calcium channels in myogenic tone of skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 283: H2239–H2243, 2002.
107. Wagner C, de Wit C, Kurtz L, Grunberger C, Kurtz A, Schweda F. Connexin40 is essential for the pressure control of renin synthesis and secretion. Circ Res 100: 556–563, 2007.
108. Wagner C, Kramer BK, Hinder M, Kieninger M, Kurtz A. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats. Br J Pharmacol 124: 579–585, 1998.
109. Wang L, Yin J, Nickles HT, Ranke H, Tabuchi A, Hoffmann J, Tabeling C, Barbosa-Sicard E, Chanson M, Kwak BR, Shin HS, Wu S, Isakson BE, Witzenrath M, de Wit C, Fleming I, Kuppe H, Kuebler WM. Hypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction. J Clin Invest 122: 4218–4230, 2012.
110. 2+ flux through voltage-gated channels with flow cessation in pulmonary microvascular endothelial cells. Microcirculation 11: 517–526, 2004.
111. 2+ channels mediate vaso-occlusion of sickled erythrocytes in lung microcirculation. Circ Res 93: 346–353, 2003.
112. 2+ channel currents in undifferentiated mammalian NG108-15 cells. J Physiol 510: 347–360, 1998.
113. Yamamoto E, Kataoka K, Dong YF, Nakamura T, Fukuda M, Nako H, Ogawa H, Kim-Mitsuyama S. Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats. J Hypertens 28: 1321–1329, 2010.
114. Zhong X, Liu JR, Kyle JW, Hanck DA, Agnew WS. A profile of alternative RNA splicing and transcript variation of CACNA1H, a human T-channel gene candidate for idiopathic generalized epilepsies. Hum Mol Genet 15: 1497–1512, 2006.
115. Zhou C, Chen H, Lu F, Sellak H, Daigle JA, Alexeyev MF, Xi Y, Ju J, van Mourik JA, Wu S. Cav3.1 (alpha1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 292: L833–L844, 2007.
116. Zhou C, Wu S. T-type calcium channels in pulmonary vascular endothelium. Microcirculation 13: 645–656, 2006.